PortfoliosLab logoPortfoliosLab logo
FUNC vs. AMRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FUNC vs. AMRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First United Corporation (FUNC) and Amneal Pharmaceuticals, Inc. (AMRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FUNC achieves a 20.19% return, which is significantly lower than AMRX's 45.40% return. Over the past 10 years, FUNC has outperformed AMRX with an annualized return of 18.95%, while AMRX has yielded a comparatively lower -5.11% annualized return.


FUNC

1D
0.68%
1M
-0.30%
6M
16.63%
YTD
20.19%
1Y
41.62%
3Y*
41.38%
5Y*
24.66%
10Y*
18.95%
ALL TIME*
5.23%

AMRX

1D
-0.97%
1M
6.82%
6M
33.92%
YTD
45.40%
1Y
133.97%
3Y*
79.45%
5Y*
30.02%
10Y*
-5.11%
ALL TIME*
11.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$32.37M$32.67M$30.54M
$1.53M$1.27M$1.04M

FUNC vs. AMRX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FUNC
First United Corporation
20.19%14.29%48.25%25.24%8.04%25.12%-33.27%54.43%-7.20%9.09%
AMRX
Amneal Pharmaceuticals, Inc.
45.40%59.09%30.48%205.03%-58.46%4.81%-5.19%-64.38%-18.74%25.66%

Correlation

The correlation between FUNC and AMRX is 0.28, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.28

Correlation (3Y)
Balances recent behavior with more history.

0.24

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.14

Correlation (10Y)
Provides a long-term view across more market conditions.

0.13

Correlation (All Time)
Calculated using the full available price history since Jan 15, 2009

0.08

Over the past year, FUNC and AMRX have become more correlated (0.28) than their long-term average of 0.08, meaning their price movements have been converging.

Fundamentals

Market Cap

FUNC:

$284.87M

AMRX:

$5.85B

EPS

FUNC:

$3.90

AMRX:

$0.48

PE Ratio

FUNC:

11.31

AMRX:

37.97

PEG Ratio

FUNC:

0.95

AMRX:

1.32

PS Ratio

FUNC:

2.36

AMRX:

1.92

Total Revenue (TTM)

FUNC:

$121.46M

AMRX:

$3.12B

Gross Profit (TTM)

FUNC:

$86.21M

AMRX:

$1.23B

EBITDA (TTM)

FUNC:

$36.69M

AMRX:

$447.79M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FUNC vs. AMRX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FUNC
FUNC Risk / Return Rank: 8282
Overall Rank
FUNC Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
FUNC Sortino Ratio Rank: 8181
Sortino Ratio Rank
FUNC Omega Ratio Rank: 7979
Omega Ratio Rank
FUNC Calmar Ratio Rank: 8585
Calmar Ratio Rank
FUNC Martin Ratio Rank: 8282
Martin Ratio Rank

AMRX
AMRX Risk / Return Rank: 9797
Overall Rank
AMRX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
AMRX Sortino Ratio Rank: 9898
Sortino Ratio Rank
AMRX Omega Ratio Rank: 9797
Omega Ratio Rank
AMRX Calmar Ratio Rank: 9797
Calmar Ratio Rank
AMRX Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FUNC vs. AMRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First United Corporation (FUNC) and Amneal Pharmaceuticals, Inc. (AMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FUNCAMRXDifference
Sharpe ratioReturn per unit of total volatility

-2.73

Sortino ratioReturn per unit of downside risk

-2.59

Omega ratioGain probability vs. loss probability

1.26

1.58

-0.32

Calmar ratioReturn relative to maximum drawdown

2.74

6.07

-3.33

Martin ratioReturn relative to average drawdown

6.03

15.13

-9.09

FUNC vs. AMRX - Sharpe Ratio Comparison

The current FUNC Sharpe Ratio is 1.35, which is lower than the AMRX Sharpe Ratio of 4.08. The chart below compares the historical Sharpe Ratios of FUNC and AMRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FUNC vs. AMRX - Drawdown Comparison

The maximum FUNC drawdown since its inception was -85.84%, smaller than the maximum AMRX drawdown of -97.52%. Use the drawdown chart below to compare losses from any high point for FUNC and AMRX.


Loading charts...

Drawdown Indicators


FUNCAMRXDifference

Max Drawdown

Largest peak-to-trough decline

-85.84%

-97.52%

+11.68%

Max Drawdown (1Y)

Largest decline over 1 year

-13.90%

-22.25%

+8.35%

Max Drawdown (3Y)

Largest decline over 3 years

-37.76%

-26.80%

-10.96%

Max Drawdown (5Y)

Largest decline over 5 years

-44.90%

-78.29%

+33.39%

Max Drawdown (10Y)

Largest decline over 10 years

-54.91%

-95.93%

+41.02%

Current Drawdown

Current decline from peak

-3.87%

-64.30%

+60.43%

Average Drawdown

Average peak-to-trough decline

-30.85%

-54.42%

+23.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.31%

8.91%

-2.60%

Volatility

FUNC vs. AMRX - Volatility Comparison

The current volatility for First United Corporation (FUNC) is 6.58%, while Amneal Pharmaceuticals, Inc. (AMRX) has a volatility of 9.86%. This indicates that FUNC experiences smaller price fluctuations and is considered to be less risky than AMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FUNCAMRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.58%

9.86%

-3.28%

Volatility (6M)

Calculated over the trailing 6-month period

17.12%

25.71%

-8.59%

Volatility (1Y)

Calculated over the trailing 1-year period

28.25%

33.29%

-5.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.72%

50.81%

-21.09%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.82%

65.25%

-32.43%

Dividends

FUNC vs. AMRX - Dividend Comparison

FUNC's dividend yield for the trailing twelve months is around 2.36%, while AMRX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018
AMRX
Amneal Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FUNC
First United Corporation
2.36%2.46%2.43%3.32%3.05%3.09%3.35%1.66%1.70%

Financials

FUNC vs. AMRX - Financials Comparison

This section allows you to compare key financial metrics between First United Corporation and Amneal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

FUNC vs. AMRX - Profitability Comparison

The chart below illustrates the profitability comparison between First United Corporation and Amneal Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

FUNC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, First United Corporation reported a gross profit of 22.41M and revenue of 30.93M. Therefore, the gross margin over that period was 72.5%.

AMRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Amneal Pharmaceuticals, Inc. reported a gross profit of 334.51M and revenue of 796.20M. Therefore, the gross margin over that period was 42.0%.

FUNC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, First United Corporation reported an operating income of 8.84M and revenue of 30.93M, resulting in an operating margin of 28.6%.

AMRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Amneal Pharmaceuticals, Inc. reported an operating income of -1.30M and revenue of 796.20M, resulting in an operating margin of -0.2%.

FUNC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, First United Corporation reported a net income of 6.66M and revenue of 30.93M, resulting in a net margin of 21.5%.

AMRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Amneal Pharmaceuticals, Inc. reported a net income of 57.66M and revenue of 796.20M, resulting in a net margin of 7.2%.


Frequently Asked Questions


FUNC and AMRX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMRX has higher volatility (9.86%) compared to FUNC (6.58%). In terms of maximum drawdown, FUNC dropped -85.84% vs AMRX's -97.52%.

AMRX currently has the higher Sharpe Ratio (4.08 vs 1.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FUNC and AMRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer